Recombinant shingles vaccine linked to fewer cardiovascular events in Nature Medicine
Louis shares a 2026 Nature Medicine study comparing recombinant (Shingrix) and live attenuated shingles vaccines as a natural experiment. The recombinant vaccine was associated with lower incidence of cardiovascular events, adding to possible Alzheimer's protection.
